TM6SF2 and cryohydrocytosis: Further studies with large sample sizes, simultaneous assessment of metabolic and lipid related histological profiles and having functional analyses support in diverse ethnicities may elucidate potential role and clinical utility of PNPLA3 and TM6SF2 genetic testing in CHC mediated liver scarring.